MariMed To Design, Develop And Manage State Of The Art Cannabis Production Facility

Ron Strider

Well-Known Member
NEWTON, Mass. and NEW BEDFORD, Mass., - MariMed Inc., (OTCQB:MRMD) today announced the purchase of a 137,500 sq. ft. industrial building on 17 acres at 167 John Vertente Blvd., in the New Bedford, Mass., industrial park for a purchase price of $6,895,000. MariMed will develop approximately 70,000 sq. ft. into a full service state of the art medical cannabis cultivation and production facility that has been leased to ARL Healthcare, Inc. (ARL), a Massachusetts not for profit corporation. MariMed assisted ARL Healthcare in its successful application to be awarded a Massachusetts Registered Marijuana Dispensary (RMD) License for cultivation, production, and dispensing of medical cannabis. Under the license, and in agreement with the City of New Bedford, this facility will be used solely to cultivate and produce cannabis medicine and related products. These products will be distributed to patients licensed by the Massachusetts Dept. of Public Health at three ARL dispensaries in other municipalities.

New Bedford Mayor Jon Mitchell stated, "The acquisition of the John Vertente Boulevard site is an important milestone because it brings us that much closer to the day when the City is able to share in ARL's success under the Host Community Agreement we negotiated in 2016. Under our Agreement, once the facility is operational, ARL will provide substantial annual benefits to the City and residents of New Bedford, including significant mitigation payments, the hiring of local workers, and the use local small businesses. Based on the company's community-oriented approach and the effective working relationship we have developed, I have every expectation ARL will succeed here in New Bedford."

MariMed will assist ARL in the development and ongoing management of this cultivation and manufacturing facility. ARL expects to employ 50 to 100 people and commence cultivation in the first quarter of 2018, with the first products in dispensaries in second or third quarter of 2018, pending receipt of state approvals.

"As a Massachusetts-based company, we congratulate our neighbor ARL on their successful license application and are eager to help them become the best medical cannabis company in this State to provide high quality, safe cannabis medicine and treatments to licensed patients in need of consistent relief," stated Jon Levine, MariMed CFO. "This property purchase represents the continuing execution of MariMed's strategy to acquire assets that will, in turn, increase revenue and earnings for all of our business units and generate tax revenue for the state."

"There is no substitute for experience, and that is why we chose MariMed to design, build out and optimize our cultivation, production and dispensary facilities," noted Kenneth Housman, president of ARL Healthcare, Inc. "MariMed's standard operating procedures and best practices have proven successful with its medical cannabis clients in multiple states."

About MariMed Inc.:

MariMed is an industry leader in the development and operation of state licensed regulatory compliant cannabis cultivation, production, and dispensary facilities in multiple states across the country. These facilities are models of excellence in horticultural principals, cannabis production, product development, and dispensary operations. MariMed is on the forefront of precision dosed branded products for the treatment of specific medical symptoms. MariMed currently distributes its branded products in select states and is expanding licensing and distribution to numerous additional states encompassing thousands of dispensaries. MariMed Inc., is one of the 17 top-performing public cannabis companies in the U.S. tracked on the U.S. Marijuana Index, (The Marijuana Index - Cannabis Stock Quotes and News_ - The Marijuana Index For Publicly Traded Companies) and CannabIndex. For additional information, visit MariMed Advisors | The Premier Cannabis Consultants

About ARL Healthcare,Inc.

ARL Healthcare, Inc., is a Massachusetts not for profit corporation that has been awarded a Registered Marijuana Dispensary (RMD License) by the State of Massachusetts. It will operate a cultivation and production manufacturing facility in New Bedford and dispensaries in Middleborough and Norwood, Massachusetts.

Forward Looking Statements:

This release contains certain forward-looking statements and information relating to MariMed Inc., that is based on the beliefs of MariMed Inc. management, as well as assumptions made by and information currently available to the Company. Such statements reflect the current views of the Company with respect to future events including estimates and projections about its business based on certain assumptions of its management, including those described in this Release. These statements are not guarantees of future performance and involve risk and uncertainties that are difficult to predict, including, among other factors, changes in demand for the Company's services and products, changes in the economic environment and changes in technology. Additional risk factors are included in the Company's public filings with the SEC. Should one or more of these underlying assumptions prove incorrect, actual results may vary materially from those described herein as "hoped," "anticipated," "believed," "planned, "estimated," "preparing," "potential," "expected" or words of a similar nature. The Company does not intend to update these forward-looking statements. None of the content of any of the websites of any other party referred to herein (even if a link is provided for your convenience) is incorporated into this release and the Company assumes no responsibility for any of such content.

News Moderator: Ron Strider 420 MAGAZINE ®
Author: Julie Shepherd
Contact: Contact Us | MariMed Advisors
Website: MariMed Advisors | The Premier Cannabis Consultants

Welcome to the 420 Press Release Forum, created as a service to our readers solely for the dissemination of cannabis and hemp industry related press releases.

It is important for us to state that all press release information published on 420Magazine.com is ONLY based on what companies and individuals (i.e. third parties not associated with 420 Magazine) publish themselves and doesn't involve any 420 Magazine's editorial opinion or review. 420 Magazine takes no responsibility for and disclaims the information available in form of press releases across our website.

Some press releases may be confusing at first reading without additional explanation. In such case you should contact the press release author, either the company or the individual listed as the contact on the press release itself, with any additional questions regarding the information presented on their press release.

420 Magazine has zero tolerance towards objectionable and controversial PR materials published on its website. Any PR material found to be involved into a dispute, in one way or another, and is having one or more complaints received at 420 Magazine, against it supported with enough evidences that clearly indicate, in one way or another, it is harmful, even in a remote way, to the interest of 3rd parties is ground for taking the respective press release permanently down, without prior notice.
 
Back
Top Bottom